Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 37.9M | 34.3M | 34.8M | 29.9M |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 9.7M | -14.5M | 9.3M | 8.8M |
Other operating expenses | 0 | -1.1M | 261K | 217K |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 23.0M | 19.9M | 19.8M | 14.7M |
Tax provision | 5.5M | 4.9M | 4.7M | 3.6M |
Net income | 17.5M | 15M | 15.2M | 11.1M |
Basic EPS | 0.1 | — | 0.1 | 0.1 |
Diluted EPS | 0.1 | — | 0.1 | 0.1 |
Basic average shares | 221.9M | — | 223.0M | 221.5M |
Diluted average shares | 221.9M | — | 223.0M | 221.5M |
EBITDA | — | — | — | — |
Net income from continuing op. | 17.5M | 15M | 15.2M | 11.1M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |